Scandinavian ChemoTech AB’s Shares Offering

Moll Wenden advised Scandinavian ChemoTech AB on the deal.Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical technology…

This content is for Standard 1 Year members only.
Login Join Now
Maha Kanaan

Author: Maha Kanaan

This content is for Standard 1 Year members only.
Login Join Now